Narrow search
Showing 71 - 80 of 226,824
Cover Image
Performance Indicators of Pharmaceutical Firms (SMES) in North India Promoting the IPR Culture
Sharma, Dr. Bhavana - 2022
perceived in the pharmaceutical industry of India, although small and middle-sized pharmaceutical firms are progressively …
Persistent link: https://www.econbiz.de/10013296176
Cover Image
Envisioning the challenges of the pharmaceutical sector in the Indian health-care industry : a scenario analysis
Festa, Giuseppe; Kolte, Ashutosh; Carli, Maria Rosaria; … - In: The journal of business & industrial marketing 37 (2022) 8, pp. 1662-1674
Persistent link: https://www.econbiz.de/10013401898
Cover Image
The politics of the pharmaceutical industry and access to medicines : world pharmacy and India
Löfgren, Hans (ed.); Löfgren, Hans (contributor) - 2013
Persistent link: https://www.econbiz.de/10014005775
Cover Image
Prospective Areas of Intellectual Property Rights in Indian Pharmaceutical Companies
HC, Bindusha - 2022
Intellectual Assets has become the pre-eminent resource for creating economic wealth. Intellectual Assets has contributed to the creation of whole new types of businesses and ways of doing business. In the Knowledge based industries many firms have large amounts of Intellectual Assets such as...
Persistent link: https://www.econbiz.de/10013308807
Cover Image
Effects of Trips Agreement on Indian Pharmaceutical Patenting
Pai, Rimpa - 2023
The TRIPS Agreement obligated India to amend its patent laws to meet the minimum standard of patent protection and … patentability. In 2005, India amended its Patent Act to comply with TRIPS, which resulted in the removal of several provisions that … India. It discusses the challenges faced by the Indian pharmaceutical industry and the strategies adopted by India to …
Persistent link: https://www.econbiz.de/10014347932
Cover Image
Impact of TRIPS in India : An Access to Medicines Perspective
Malhotra, Prabodh - 2010
In India today only 35 percent of people have access to medicines. This book examines the rise of drug prices in India …, and develops a new healthcare model, which if implemented, would extend access to medicines to India's entire population …
Persistent link: https://www.econbiz.de/10012053872
Cover Image
Cross-national price differences for pharmaceuticals : how large, and why?
Danzon, Patricia Munch; Chao, Li-wei - In: Journal of health economics 19 (2000) 2, pp. 159-195
Persistent link: https://www.econbiz.de/10001511446
Cover Image
Waiting for new medicines : how does Canada compare to the United States and Europe?
Rawson, Nigel S. B. - 2023
Persistent link: https://www.econbiz.de/10014282191